Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols.


Journal

Le infezioni in medicina
ISSN: 2532-8689
Titre abrégé: Infez Med
Pays: Italy
ID NLM: 9613961

Informations de publication

Date de publication:
01 03 2021
Historique:
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 11 3 2021
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic worldwide. On a daily basis the number of deaths associated with COVID-19 is rapidly increasing. The main transmission route of SARS-CoV-2 is through the air (airborne transmission). This review details the airborne transmission of SARS-CoV-2, the aerodynamics, and different modes of transmission (e.g. droplets, droplet nuclei, and aerosol particles). SARS-CoV-2 can be transmitted by an infected person during activities such as expiration, coughing, sneezing, and talking. During such activities and some medical procedures, aerosols and droplets contaminated with SARS-CoV-2 particles are formed. Depending on their sizes and the environmental conditions, such particles stay viable in the air for varying time periods and can cause infection in a susceptible host. Very few studies have been conducted to establish the mechanism or the aerodynamics of virus-loaded particles and droplets in causing infection. In this review we discuss the various forms in which SARS-CoV-2 virus particles can be transmitted in air and cause infections.

Identifiants

pubmed: 33664169

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-19

Auteurs

Ali A Rabaan (AA)

Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Shamsah H Al-Ahmed (SH)

Specialty Paediatric Medicine, Qatif Central Hospital, Qatif, Saudi Arabia.

Maysaa Al-Malkey (M)

Tropical Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq.

Roua Alsubki (R)

Department of Clinical Laboratory Sciences, Chair of Medical and Molecular Genetics Research, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Sayeh Ezzikouri (S)

Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.

Fadel Hassan Al-Hababi (FH)

Virology Department, Riyadh Regional Laboratory, Riyadh, Saudi Arabia.

Ranjit Sah (R)

Department of Microbiology, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.

Abbas Al Mutair (A)

School of Nursing, Wollongong University, Australia; Research Center, Almoosa Specialist Hospital, Alahsa, Saudi Arabia.

Saad Alhumaid (S)

Administration of Pharmaceutical Care, Ministry of Health, Alahsa, Saudi Arabia.

Jaffar A Al-Tawfiq (JA)

Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Awad Al-Omari (A)

School of Medicine, Critical Care and Infection Control Department, Al-Faisal University, Riyadh, Saudi Arabia; Dr. Sulaiman Al-Habib Medical Group, Riyadh, Saudi Arabia.

Ayman M Al-Qaaneh (AM)

Department of Genetic Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; Clinical Pharmacy Services Division, Pharmacy Services Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Manaf Al-Qahtani (M)

Department of Medicine, Royal Medical Services, Bahrain Defence Force Hospital, Manamah, Bahrain; Department of Medicine, Royal College of Surgeons in Ireland-Bahrain Medical University, Manamah, Bahrain.

Raghavendra Tirupathi (R)

Penn State University School of Medicine, Hershey, PA, USA; Wellspan Chambersburg and Waynesboro (Pa.) Hospitals, Chambersburg, PA, USA; Department of Pathology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Mohammad A Al Hamad (MA)

Department of Pathology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Nadira A Al-Baghli (NA)

Directorate of Health Affairs, Ministry of Health, Dammam, Saudi Arabia.

Tarek Sulaiman (T)

King Fahad Medical City, Riyadh, Saudi Arabia.

Arwa Alsubait (A)

King Abdullah international medical research center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs.

Rachana Mehta (R)

National Public Health Laboratory, Kathmandu, Nepal.

Elfadil Abass (E)

Department of Clinical Laboratory Science, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Maha Alawi (M)

Department of Medical Microbiology and Parasitology, King Abdulaziz University, Jeddah, Saudi Arabia; Infection Control and Environmental Health Unit, King Abdulaziz University Hospital, Faculty of Medicine. Jeddah, Saudi Arabia.

Fatimah Alshahrani (F)

Division Of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.

Dhan Bahadur Shrestha (DB)

Department of Emergency Medicine, General Practice, Mangalbare Hospital, Urlabari-03, Morang, Nepal.

Mohmed Isaqali Karobari (MI)

Conservative Dentistry Unit, School of Dental Sciences, University Sains Malaysia, Health Campus, Kelantan, Malaysia.

Samuel Pecho-Silva (S)

Pneumology Service, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru; Master in Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru.

Kovy Arteaga-Livias (K)

Faculty of Medicine, Universidad Nacional Hermilio Valdizan, Huanuco, Peru; Hospital II Huanuco, EsSalud, Huanuco, Peru; Facultad de Ciencias de la Salud, Universidad Cientifica del Sur, Lima, Peru.

D Katterine Bonilla-Aldana (DK)

Semillero de Investigacion en Zoonosis (SIZOO), Grupo de Investigacion BIOECOS, Fundacion Universitaria Autonoma de las Americas, Sede Pereira, Pereira, Risaralda, Colombia; Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.

Alfonso J Rodriguez-Morales (AJ)

Master in Clinical Epidemiology and Biostatistics, Universidad Cientificadel Sur, Lima, Peru; Facultad de Ciencias de la Salud, Universidad Cientifica del Sur, Lima, Peru; Public Health and infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia; Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH